Behavioral Finance
April 21, 2026
Hindsight bias — Fischhoff's 'I-knew-it-all-along' effect — silently corrupts the Indian retail investor's feedback loop. Here's the academic source, the SEBI/IIM-B evidence, the decision-journal counter-measure, and a numbers-rich positive illustrative case from Titan Biotech's FY25 audited filings.
April 21, 2026
How the 1968 Altman Z-Score and its modified Z'' variant work, why every Indian retail investor should run them as a first solvency filter, and how Titan Biotech (BSE: 524717) FY25 audited numbers illustrate a textbook safe-zone balance sheet.
April 20, 2026
The CFO/PAT ratio is the single fastest earnings-quality check any Indian value investor can run — and Titan Biotech FY25 audited numbers show what disciplined cash-backed profits actually look like.
April 20, 2026
Tversky & Kahneman's 1973 availability heuristic explains why Indian retail investors chase recent headlines. A detailed teaching post with an illustrative Titan Biotech FY25 case study on availability-resistant corporate behaviour.